NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001707

Registered date:16/02/2009

Clinical study of ghrelin administration on diabetic neuropathy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedtype2 diabetes mellitus
Date of first enrollment2008/12/01
Target sample size15
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)two weeks ghrelin administration

Outcome(s)

Primary OutcomeImprovement of diabetic neuropathy. Changes of glucose metabolism and appetite.
Secondary OutcomeInsulin secretion capacity.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum70years-old
GenderMale and Female
Include criteriaType2 diabetes with diabetic neuropathy. HbA1c<9.1%
Exclude criteriaInsulin treatment. Severe liver or renal dysfunction. Severe heart diseases. Proliferative diabetic retinopathy. Medication with epalrestat, anti-eplepsy drugs, or mexiletine. Pregnant women.

Related Information

Contact

public contact
Name Hiroaki Ueno
Address 5200, kihara, Kiyotake, Miyazaki, Japan Japan
Telephone 0985-85-9246
E-mail intron@med.miyazaki-u.ac.jp
Affiliation Miyazaki Medical College, University of Miyazaki Neurology, Respirology, Endocrinology and Metabolism
scientific contact
Name Masamitsu Nakazato
Address 5200, kihara, Kiyotake, Miyazaki, Japan Japan
Telephone 0985-85-9246
E-mail
Affiliation Miyazaki Medical College, University of Miyazaki Neurology, Respirology, Endocrinology and Metabolism